Mediolanum Cardio Research joins the Avicenna Alliance for the start of 2020!
The Avicenna Alliance is proud to announce the newest addition to its list of members: Mediolanum Cardio Research.
Mediolanum Cardio Research (MCR) Srl is an independent Contract Research Organisation (CRO) established in Milano (Italy) since 2002 MCR have gained extensive experience in regulatory authorizations and reporting, project management, monitoring, data management and statistics for sponsored and no-profit clinical trials both pharmacological and Medical Devices.
MCR has also internally developed an electronic CRF (called IDAS), compliant with FDA 21 CFR part 11 and GDPR. In addition, MCR has an internal Core-lab specialised in QCA readings.
MCR is proud to be partner of the Horizon 2020 InSilc project (In-silico trials for drug-eluting BVS design, development and evaluation. Project 777119). One of MCR tasks is to identify and elaborate on the regulatory aspects which have to be fulfilled in order to have in silico trials accepted as part of the clinical assessment of new coronary stents. The adoption of modelling and simulations entails ethical issues and methodological constraints: being member of the Avicenna Alliance could provide an exceptional opportunity to gain and to provide contribution to the development of guidelines for a proper adoption of in-silico clinical trials.
More information about Mediolanum Cardio Research can be found here.